13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 4 managers

Reported value

$2.05M

Holders

4

+0 new · −0 exited

Holders’ est. mark

$19.5K

Price effect on 2 books still in the name

Largest holder

$1.67M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC120.6K$1.67MHeld
Henshaw Capital LLC10.2K$363.3K$18.5KAdded$18.5K
Leonteq Securities AG520$18.5K$946Added$946

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.